Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/36920
Appears in Collections:Senior Management Team Journal Articles
Peer Review Status: Unrefereed
Title: Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer
Author(s): de Paula, Bruno
Cexus, Olivier
Townsend, Paul
Crocamo, Susanne
Contact Email: catherine.stewart@stir.ac.uk
Keywords: Her2-positive breast cancer
Zoledronic acid
Pathological complete response rate
Issue Date: Jan-2025
Date Deposited: 13-Jan-2025
Citation: de Paula B, Cexus O, Townsend P & Crocamo S (2025) Zoledronic-acid plus neoadjuvant therapy is associated with provoking outcomes in Her2-positive breast cancer. <i>Asian Journal of Surgery</i>, 48 (1), pp. 566-567. https://doi.org/10.1016/j.asjsur.2024.07.024
Abstract: First paragraph: Dear Editor, We recently came across Mei Liu et al meta-analysis, a comprehensive study published in 2023, and wish to discuss a few aspects.
DOI Link: 10.1016/j.asjsur.2024.07.024
Rights: © 2024 Asian Surgical Association and Taiwan Society of Coloproctology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Licence URL(s): http://creativecommons.org/licenses/by-nc-nd/4.0/

Files in This Item:
File Description SizeFormat 
1-s2.0-S1015958424013782-main.pdfFulltext - Published Version181.77 kBAdobe PDFView/Open



This item is protected by original copyright



A file in this item is licensed under a Creative Commons License Creative Commons

Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.